ChengDa Pharmaceuticals Co.,Ltd. — Investor Relations & Filings
ChengDa Pharmaceuticals Co., Ltd. specializes in the research, development, manufacturing, and global distribution of active pharmaceutical ingredients (APIs) and pharmaceutical intermediates. The company maintains a diverse product portfolio with a significant focus on the L-carnitine series, including levocarnitine and its derivatives, serving as a major global supplier. Its therapeutic areas of expertise encompass cardiovascular health, metabolic disorders, and anti-infective treatments. ChengDa Pharmaceuticals operates advanced production facilities that adhere to international quality standards, including Good Manufacturing Practice (GMP) certifications from regulatory bodies such as the FDA and EDQM. The organization emphasizes technological innovation and process optimization to provide high-purity chemical components for the global market, supporting both generic and proprietary drug development.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 募集资金管理制度 | 2025-10-27 | Chinese | |
| 内部审计制度 | 2025-10-27 | Chinese | |
| 总经理工作细则 | 2025-10-27 | Chinese | |
| 信息披露管理制度 | 2025-10-27 | Chinese | |
| 独立董事候选人声明与承诺(周钧明) | 2025-10-27 | Chinese | |
| 第五届董事会提名委员会关于独立董事候选人任职资格的审查意见 | 2025-10-27 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 37155710 | 募集资金管理制度 | 2025-10-27 | Chinese | ||
| 37155706 | 内部审计制度 | 2025-10-27 | Chinese | ||
| 37155699 | 总经理工作细则 | 2025-10-27 | Chinese | ||
| 37155693 | 信息披露管理制度 | 2025-10-27 | Chinese | ||
| 37155685 | 独立董事候选人声明与承诺(周钧明) | 2025-10-27 | Chinese | ||
| 37155676 | 第五届董事会提名委员会关于独立董事候选人任职资格的审查意见 | 2025-10-27 | Chinese | ||
| 37155669 | 第五届监事会第十四次会议决议公告 | 2025-10-27 | Chinese | ||
| 37155663 | 第五届董事会第十四次会议决议公告 | 2025-10-27 | Chinese | ||
| 37155659 | 关于修订《公司章程》、修订及制定治理相关制度的公告 | 2025-10-27 | Chinese | ||
| 37155650 | 董事会审计委员会工作细则 | 2025-10-27 | Chinese | ||
| 37155642 | 控股股东、实际控制人行为规范 | 2025-10-27 | Chinese | ||
| 37155632 | 内部控制缺陷认定标准 | 2025-10-27 | Chinese | ||
| 37155626 | 独立董事提名人声明与承诺(姜林) | 2025-10-27 | Chinese | ||
| 37155618 | 2025年三季度报告 | 2025-10-27 | Chinese | ||
| 37155614 | 董事、高级管理人员薪酬管理制度 | 2025-10-27 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
ChengDa Pharmaceuticals Co.,Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/56137/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=56137 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=56137 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=56137 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 56137}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for ChengDa Pharmaceuticals Co.,Ltd. (id: 56137)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.